|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.67/-1.91
|
企业价值
493.83M
|
资产负债 |
每股账面净值
3.59
|
现金流量 |
现金流量率
--
|
损益表 |
收益
20.76M
|
每股收益
0.30
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/29 08:29 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders. |